Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD. [electronic resource]
Producer: 20190326Description: 160-167 p. digitalISSN:- 2160-7648
- Administration, Oral
- Adolescent
- Adult
- Area Under Curve
- Attention Deficit Disorder with Hyperactivity -- drug therapy
- Biological Availability
- Central Nervous System Stimulants -- adverse effects
- Cross-Over Studies
- Delayed-Action Preparations -- adverse effects
- Dietary Fats -- pharmacology
- Fasting -- metabolism
- Female
- Food-Drug Interactions
- Healthy Volunteers
- Humans
- Male
- Methylphenidate -- adverse effects
- Tablets
- Therapeutic Equivalency
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.